We translate complex investment strategies and scientific innovations into clear, valuation-driving narratives. A strategic branding partner for Private Equity, Life Sciences, and Infrastructure.
Brand Value for Capital, Science, and Real Assets.
01. Private Capital & Portfolio Value
We partner with Private Equity, Venture Capital, and Family Offices to align brand narratives with exit strategies. From fundraising decks to post-acquisition value creation, we prepare portfolio companies for IPOs, M&A, and Rapid Scaling.
- Key Experience: Legatum, ePlanet Capital, GHO Capital.
02. Life Sciences & Healthcare
We serve as long-term brand stewards for highly regulated businesses. We bridge the gap between complex R&D and human outcomes, creating trusted brands for patients, providers, and investors.
- Key Experience: Oxford Biomedica, Aldevron, Novartis.
03. Infrastructure & Real Assets
We help built-environment and infrastructure leaders articulate their value in a Net Zero world. We transform heavy industry brands into sustainable, investment-ready assets.
- Key Experience: Aureos (Keltbray), Laing O’Rourke.
Clarity Drives Valuation
In high-stakes sectors like Private Capital, Life Sciences, and Real Assets, confusion is expensive. To raise funds, scale operations, or secure an exit, you need more than just “differentiation”—you need absolute clarity. We translate complex business strategies into human narratives that build trust and drive commercial value. From Seed to IPO to Acquisition, we ensure your story works as hard as your assets.
We make
design work
Latest
- Strategic Rebrand for Aureos (formerly Keltbray Infrastructure) Following the acquisition by EMK Capital, thinkerdoer was commissioned to rename and rebrand Keltbray Infrastructure Services. We launched Aureos: a new identity that positions the independent business as the UK’s leader in decarbonised energy and transport infrastructure.
- 16 Years of Trusted Partnership with OXB thinkerdoer has been commissioned for the 16th consecutive year to produce the Annual & Sustainability Report for Oxford Biomedica. We are proud to continue supporting the FTSE-listed business in communicating their value creation story to stakeholders.
- Oxford Biomedica transforms to OXB thinkerdoer are proud to have worked alongside the Oxford Biomedica leadership team to rebrand the company as OXB. The new visual identity reinforces their strategic transformation into a global, pure-play cell and gene therapy CDMO.
- Median Technologies: US Brand Experience thinkerdoer supported the US launch of the eyonis™ brand for Median Technologies, delivering a bespoke brand experience for their key market activation at RSNA in Chicago.
- Digital Platform for US-based Agathos thinkerdoer launches the new digital platform for US-based Agathos Biologics. This marks an exciting next step in the commercialization strategy for this high-potential brand we helped create from scratch.
- Genovac: Brand Independence following MBO Following their management buyout from Aldevron, thinkerdoer partnered with the new leadership team to relaunch Genovac as an independent entity. We delivered a complete strategic overhaul—including new messaging, visual identity, and digital platforms—to establish their standalone market value.
- Clarifying the Investment Narrative for OxSonics thinkerdoer collaborated with OxSonics to sharpen their brand story ahead of a critical funding stage. We translated their complex proprietary technology into a clear, investor-focused narrative, deploying a new digital presence designed to secure their next phase of growth.